Bayesian Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $656K | Buy |
16,600
+8,100
| +95% | +$320K | 0.1% | 243 |
|
|
2025
Q1 | $256K | Buy |
+8,500
| New | +$256K | 0.04% | 432 |
|
|
2023
Q2 | – | Sell |
-21,227
| Closed | -$759K | – | 929 |
|
|
2023
Q1 | $759K | Buy |
+21,227
| New | +$759K | 0.09% | 284 |
|
|
2022
Q3 | – | Sell |
-9,063
| Closed | -$336K | – | 854 |
|
|
2022
Q2 | $336K | Buy |
+9,063
| New | +$336K | 0.06% | 437 |
|
|
2020
Q2 | – | Sell |
-5,300
| Closed | -$251K | – | 639 |
|
|
2020
Q1 | $251K | Buy |
5,300
+1,815
| +52% | +$86K | 0.05% | 520 |
|
|
2019
Q4 | $211K | Buy |
+3,485
| New | +$211K | 0.04% | 523 |
|
|
2017
Q1 | – | Sell |
-10,138
| Closed | -$485K | – | 543 |
|
|
2016
Q4 | $485K | Buy |
+10,138
| New | +$485K | 0.12% | 314 |
|